INTIMA BIOSCIENCES
Intima Biosciences is a cell therapy business that focuses on solid tumor cancer cures. With its Molecular and Cell Therapy (MCT) GMP gene and cell therapy production facility, Intima Bioscience is undertaking a clinical trial at the University of Minnesota Masonic Cancer Center. It is headquartered in New York City.
INTIMA BIOSCIENCES
Industry:
Biotechnology
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.intimabioscience.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins Sitelinks Search Box
Similar Organizations
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Current Employees Featured
Campbell Murray President & Chief Operating Officer @ Intima Biosciences
President & Chief Operating Officer
2020-01-01
Alessandro Riva Chief Executive Officer @ Intima Biosciences
Chief Executive Officer
2021-09-01
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-10 | Intima Bioscience Appoints Alessandro Riva, M.D., as Chief Executive Officer |
Official Site Inspections
http://www.intimabioscience.com Semrush global rank: 4.46 M Semrush visits lastest month: 2.45 K
- Host name: 172.67.151.153
- IP address: 172.67.151.153
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Intima Biosciences"
Intima Bioscience
A clinical stage gene and cell therapy company focused on curative intent in solid tumor cancer CHECKPOINT CELL THERAPY THE NEXT GENERATION OF CANCER PLATFORM TECHNOLOGY CISH: a novel immune checkpoint T …See details»
Intima Biosciences - Crunchbase Company Profile & Funding
Intima Biosciences is a cell therapy business that focuses on solid tumor cancer cures. With its Molecular and Cell Therapy (MCT) GMP gene and cell therapy production facility, Intima …See details»
Intima Bioscience - LinkedIn
Intima Bioscience | 915 followers on LinkedIn. A clinical stage gene and cell therapy company focused on curative intent in solid tumor cancerSee details»
Intima Bioscience - 2025 Company Profile - Tracxn
Mar 25, 2025 Intima Bioscience aims to develop a gene and cell therapeutic platform for gastrointestinal cancer. The company is under the clinical trial phase and conducting …See details»
Intima Bioscience Company Profile | Management and Employees …
Www.intimabioscience.com . Intima Bioscience Profile and History. Intima Bioscience is a clinical stage gene and cell therapy company focused on developing next-generation therapies for …See details»
Intima Bioscience Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Intima Bioscience Inc. of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
Company: Intima Bioscience - CRISPR Medicine
Intima Bioscience is a clinical-stage gene and cell therapy company focused on developing cures for solid cancers. The company develops tumour-infiltrating lymphocytes (TILs) in which the …See details»
Intima Bioscience - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Intima Bioscience Company Profile -Sales, Contacts, Competitors – …
Intima Bioscience is in the Biotechnical Research, Commercial industry within the Engineering, Accounting, Research, and Management Services sector and has been in business for …See details»
Intima Bioscience - Products, Competitors, Financials, Employees ...
Intima Bioscience is a clinical stage gene and cell therapy company operating in the healthcare and biotechnology sectors. Use the CB Insights Platform to explore Intima Bioscience's full …See details»
Intima Bioscience - PitchBook
Intima Bioscience General Information Description. Developer of gene and cell therapy designed for curative intent in solid tumor cancer. The company's platform specializes in clinical-stage …See details»
Intima Bioscience - Overview, News & Similar companies - ZoomInfo
Www.intimabioscience.com. Revenue <$5 Million. Industry Business Services General Business Services . Recent News & Media. No recent news or media. Overview ; Org Chart ; Who is …See details»
INTIMA BIOSCIENCE INC New York NY, 10019 - Company Profile
Free Business profile for INTIMA BIOSCIENCE INC at 3 Columbus Cir, New York, NY, 10019-8760, US. INTIMA BIOSCIENCE INC specializes in: Commercial Physical and Biological …See details»
Intima Bioscience, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Intima Bioscience, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 4 news, and 3 literature, Disease Domain:Neoplasms, Endocrinology and …See details»
Intima Bioscience - VentureRadar
Intima Bioscience is a clinical stage gene and cell therapy company focused on curative intent in solid tumor cancer. Intima Bioscience is conducting... ... Find out ...See details»
Intima Bioscience, Inc. | Insights
Feb 9, 2022 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Intima Bioscience, Inc. - discovery.patsnap.com
Https://www.intimabioscience.com. Intima Bioscience, Inc. is a company that provides Medicine and more. Intima Bioscience, Inc. is headquartered in United States New York. Intima …See details»
Working at Intima Bioscience - Glassdoor
Glassdoor gives you an inside look at what it's like to work at Intima Bioscience, including salaries, reviews, office photos, and more. This is the Intima Bioscience company profile.See details»
Intima Bioscience Appoints Alessandro Riva, M.D., as Chief …
Nov 10, 2021 Intima Bioscience announces the appointment of veteran industry executive Alessandro Riva, M.D., as Chief Executive Officer.See details»
Intima Bioscience poaches ex-Ichnos CEO with Gilead ... - Fierce …
Nov 10, 2021 RELATED: Riva to leave Gilead to lead Glenmark spinoff The study is using CRISPR gene editing in patients with gastrointestinal and colon cancers. Intima began the trial …See details»